Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADA: Once-daily raltegravir with atazanavir in HIV-1 infected patients
2008-008556-16Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Primary endpoint: Primary pharmacokinetic comparison. Started May 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-008556-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008556-16.